Mar 30, 2017 Last Updated 9:01 AM, Mar 30, 2017

Philips partners with Rhiza Foundation to launch mobile health clinic

ABN – Philips South Africa has partnered with the Rhiza Foundation to launch a mobile health clinic project.

The project will focus on delivering healthcare services to towns with little or no access to health facilities.

Diepsloot, Cosmo City and Orange Farm, in Northern Johannesburg have already been sent mobile health clinics.

Philips Healthcare general manager Jose Fernandes said: “In many African countries including South Africa, there is a chronic shortage of suitable equipment or necessary skills to facilitate safe delivery and appropriate newborn care, as well as dental care.

“By bringing healthcare directly to those most in need, shortens the waiting period and improves access which ultimately saves lives.

“Innovation as a means to improve people’s lives is at the heart of who we are at Philips and we increasingly seek engagement and co-creation opportunities with organisations like the Rhiza Foundation that can result in making a difference in the lives of South Africa citizens.”


WHO raises concerns over Ebola vaccines

ABN – Following the declaration of Liberia being Ebola free the World Health Organisation (WHO) has voiced concerns over further vaccine trials.

WHO believes that future vaccine trials will not provide enough information on the degree of protection it offers against the virus.

Sufficient data may not be collected by the two current vaccines being tested as the number of Ebola cases continues to shrink.

Dr. Marie-Paule Kieny, WHO assistant director-general for Health Systems and Innovation, said:  “The best news is we are going to zero cases, there is absolutely no doubt about that.

“It is not clear whether it will be possible to have even a hint of efficacy from these two vaccines.

“To have efficacy we must see if people are actually protected, as the number of cases is going down it is not clear whether there will be a strong robust answer to this question at the end of epidemic.”


Aspen sells injectables portfolio to Litha Pharmacare

ABN – Aspen Pharmacare has sold its portfolio of branded and generic injectables to Endo International subsidiary Litha Pharmacare for R1.6 billion (US$130 million).

The company has now turned its focus on pain and anti-infectives as it tries to simplify its business.

South African competition authorities still have to approve the transaction, which is likely to be completed in June 2015.

Endo Internation CEO Rajiv De Silva said: With the acquisition of these products from Aspen Holdings, Endo continues to grow, diversity and optimise its international portfolio and, specifically, further expand its reach into hospital and pharmacy markets in South Africa.” 


This Month's Issue

ABN v4i2 web

Subscribe to our newsletter


Featured Companies Across The Network